Site Search

... Biomarker testing helps connect cancer patients to the right treatment at the right time, often resulting in improved outcomes and quality of life. In some cases, biomarker testing may provide information that enables patients to forgo ineffective treatments and eliminate the ... which could also result in reduced health care costs. S3098/A4163 is a priority bill for the American Cancer Society Cancer Action Network (ACS CAN), which, last month as a part of their annual Cancer Action Week, dispatched its volunteers to connect with their lawmakers on the potential of ... do not cover the most appropriate biomarker testing. This results in some patients being forced to decide whether to pay out-of-pocket—a cost many cannot realistically afford--or go without the testing and hope the first treatment prescribed is the right one. Not all communities are ...

... 567 . If passed, the legislation would allow more North Carolinians to access biomarker testing, which has become an increasingly important part of cancer care. Patients who are diagnosed with certain types of cancer can receive biomarker testing to help providers determine the most effective form of treatment. It can save patients from starting treatments that ...

HARTFORD –   Yesterday, Gov. Ned Lamont signed into law S.B. 307 An Act Concerning Medicaid Coverage of Biomarker Testing . This legislation will increase Connecticut Medicaid (HUSKY Health) coverage of biomarker testing, a form of precision medicine that enables patients to receive treatments personalized to their specific disease.      The following statement can be attributed to Bryte Johnson, Director of Government Relations for the American Cancer Society Cancer Action Network (ACS CAN) in ...

Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... using a plan purchased privately such as through the marketplace. Nine percent of those who did not have biomarker testing say it was because of cost or coverage concerns. This is a significant improvement since the last time this question was asked in 2020, when 29% mentioned cost and ...